Literature DB >> 9025922

Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms.

G W Oliver1, J D Leferson, W G Stetler-Stevenson, D E Kleiner.   

Abstract

Matrix metalloproteinases are a growing family of neutral pH optima, zinc atom-dependent endopeptidases that collectively degrade all components of the extracellular matrix. This family of related proteases is further defined by their inhibition of protease activity by a class of low-molecular-weight endogenous inhibitors known as tissue inhibitors of metalloproteinases or TIMPs. Reverse zymography is an electrophoretic technique used to identify TIMP inhibitory activity within acrylamide gels. Previous methods have generally used biochemically complex sources of proteolytic activity (such as cell culture conditioned media) copolymerized with a proteinase substrate in the gel to identify the zones of inhibited proteolysis. We describe a novel system for reverse zymography using purified recombinant human gelatinase A or gelatinase B in place of conditioned media. These reverse zymograms using recombinant gelatinase have sensitivities for TIMPs that are favorable in comparison to immunoblotting techniques but have the benefit of visualizing multiple inhibitors simultaneously. We have developed and characterized these methods for the evaluation of inhibitors and have shown them to be highly sensitive, convenient, and reproducible. Both systems detect TIMPs 1, 2, and 3 simultaneously, but with differential sensitivities for TIMPs 1 and 2. Using gelatinase A the system can detect as little as 1 pg of rTIMP-2, but the limit of detection for rTIMP-1 is 40 pg. Gelatinase B shows less differential activity in that the limits of detection are 60 and 40 pg for TIMP-2 and TIMP-1, respectively. We demonstrate how these varied sensitivities of the gelatinases for the TIMPs can contribute to potential pitfalls in systems using uncharacterized reagents (i.e., conditioned media).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9025922     DOI: 10.1006/abio.1996.9895

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  31 in total

1.  Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.

Authors:  L Guedez; A J McMarlin; D W Kingma; T A Bennett; M Stetler-Stevenson; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros.

Authors:  J Barasch; J Yang; J Qiao; P Tempst; H Erdjument-Bromage; W Leung; J A Oliver
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.

Authors:  Dimitra Bourboulia; Sandra Jensen-Taubman; Matthew R Rittler; Hui Ying Han; Tania Chatterjee; Beiyang Wei; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

4.  Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets.

Authors:  Anna Radomski; Paul Jurasz; Esmond J Sanders; Christopher M Overall; Heather F Bigg; Dylan R Edwards; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

5.  Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.

Authors:  Yiping Zou; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2012-05-08       Impact factor: 2.192

6.  Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.

Authors:  Miles A Miller; Layla Barkal; Karen Jeng; Andreas Herrlich; Marcia Moss; Linda G Griffith; Douglas A Lauffenburger
Journal:  Integr Biol (Camb)       Date:  2010-12-23       Impact factor: 2.192

7.  Staphylococcal superantigen-like protein 5 inhibits matrix metalloproteinase 9 from human neutrophils.

Authors:  Saotomo Itoh; Eri Hamada; Go Kamoshida; Kana Takeshita; Teruaki Oku; Tsutomu Tsuji
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

8.  Regulation of type IV collagen gene expression and degradation in fast and slow muscles during dexamethasone treatment and exercise.

Authors:  A M Ahtikoski; E-M Riso; S O A Koskinen; J Risteli; T E S Takala
Journal:  Pflugers Arch       Date:  2003-12-18       Impact factor: 3.657

9.  Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice.

Authors:  Alfredo Santana; Carlos Medina; Maria-Cristina Paz-Cabrera; Federico Díaz-Gonzalez; Esther Farré; Antonio Salas; Marek-W Radomski; Enrique Quintero
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

10.  A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons.

Authors:  Adlane Ould-yahoui; Evelyne Tremblay; Oualid Sbai; Lotfi Ferhat; Anne Bernard; Eliane Charrat; Yatma Gueye; Ngee Han Lim; Keith Brew; Jean-Jacques Risso; Vincent Dive; Michel Khrestchatisky; Santiago Rivera
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.